Head-To-Head Review: Pheton Holdings Ltd Class A Ordinary Shares (NASDAQ:PTHL) vs. electroCore (NASDAQ:ECOR)

electroCore (NASDAQ:ECOR) and Pheton Holdings Ltd Class A Ordinary Shares (NASDAQ:PTHL) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, valuation, risk, analyst recommendations and dividends.

Analyst Ratings

This is a summary of current recommendations and price targets for electroCore and Pheton Holdings Ltd Class A Ordinary Shares, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
electroCore	0	0	2	0	3.00
Pheton Holdings Ltd Class A Ordinary Shares	0	0	0	0	0.00

electroCore currently has a consensus target price of $25.50, suggesting a potential upside of 252.21%. Given electroCore’s stronger consensus rating and higher probable upside, research analysts plainly believe electroCore is more favorable than Pheton Holdings Ltd Class A Ordinary Shares.

Earnings and Valuation

This table compares electroCore and Pheton Holdings Ltd Class A Ordinary Shares”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
electroCore	$25.18 million	2.07	-$18.83 million	($1.62)	-4.47
Pheton Holdings Ltd Class A Ordinary Shares	$448,196.00	56.39	N/A	N/A	N/A

Pheton Holdings Ltd Class A Ordinary Shares has lower revenue, but higher earnings than electroCore.

Insider & Institutional Ownership

26.7% of electroCore shares are owned by institutional investors. 19.7% of electroCore shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Profitability

This table compares electroCore and Pheton Holdings Ltd Class A Ordinary Shares’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
electroCore	-54.40%	-154.45%	-69.16%
Pheton Holdings Ltd Class A Ordinary Shares	N/A	N/A	N/A

Summary

electroCore beats Pheton Holdings Ltd Class A Ordinary Shares on 6 of the 10 factors compared between the two stocks.

About electroCore

electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

About Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd. operates as a holding company with interests in providing healthcare solutions. The firm through its subsidiaries engages in the development and commercialization of brachytherapy TPS specifically used for radioactive particle implantation, a type of radiotherapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. The company was founded on November 2, 2022 and is headquartered in Beijing, China.